Nasdaq begins ViewRay delisting proceedings

2019 09 17 16 42 0082 Viewray Astro 2019

The Nasdaq stock market has begun delisting proceedings for Image-guided radiation therapy developer ViewRay.

Trading of ViewRay's stock will be discontinued on July 26 and delisting Form 25-NSE will be filed with the Securities and Exchange Commission (SEC).

The company filed for bankruptcy on July 16. It does not plan to appeal Nasdaq's decision, it said.

Page 1 of 674
Next Page